NRC - NATIONAL RESEARCH CORP

13.39
-0.460   -3.435%

Share volume: 120,666
Last Updated: 03-03-2026
Business Services/Services – Research, Development, Testing Labs: -0.04%

PREVIOUS CLOSE
CHG
CHG%
$13.85
-0.46
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
79%
Profitability 92%
Dept financing 37%
Liquidity 23%
Performance 91%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-0.15%
1 Month
-12.31%
3 Months
-17.95%
6 Months
-10.49%
1 Year
-5.04%
2 Year
-66.70%
Key data
Stock price
$13.39
P/E Ratio 
18.01
DAY RANGE
$13.27 - $13.88
EPS 
$0.70
52 WEEK RANGE
$9.76 - $22.79
52 WEEK CHANGE
-$5.90
MARKET CAP 
294.752 M
YIELD 
3.76%
SHARES OUTSTANDING 
22.657 M
DIVIDEND
$0.12
EX-DIVIDEND DATE
03-28-2025
NEXT EARNINGS DATE
05-06-2025
BETA 
1.49
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$106,901
AVERAGE 30 VOLUME 
$141,207
Company detail
CEO: Michael D. Hays
Region: US
Website: nrchealth.com
Employees: 490
IPO year: 2013
Issue type: Common Stock
Market: XNAS
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty.

Recent news